It was recently reported that 7 of the current top 8 selling drugs are proteins. However, it has also been noted that the cost of many protein-based drugs is extremely high, making their widespread use difficult to implement. To increase the utility of such molecules, it is essential that the cost of producing them be reduced. Protein conjugation is an essential feature of many protein-based drugs including antibody-drug conjugates and PEGylated proteins. Enzymatic methods offer tremendous potential to solve the problem of specificity and streamline the process of protein conjugation. The discovery that virtually any protein can be rendered a PFTase substrate by incorporation of a tetrapeptide recognition sequence coupled with the ability of the enzyme to tolerate a plethora of modifications within the isoprenoid structure has made PFTase an attractive choice for performing enzymatic protein labeling. In the previous funding period, we demonstrated that PFTase could be used to prepare site-selectively modified proteins, and employed this method to incorporate fluorescent labels and PEG groups into proteins for therapeutic applications that were evaluated in cell culture and animal models. A total of 21 papers and one patent from this work have been published with two more currently under review. In this next funding period, we hypothesize that PFTase-catalyzed enzymatic labeling will greatly facilitate the preparation of new ?biologics? for therapeutic applications by pursuing the following Aims: (1) Create mutant forms of PFTase that alter enzyme specificity and enlarge the size of the isoprenoid substrate that can be transferred. This will be pursued to generate a completely orthogonal form of PFTase that can transfer novel isoprenoids to specific proteins. Enlarging the isoprenoid binding site will allow efficient incorporation of larger moieties including whole polymer chains; (2) Prepare protein-polymer conjugates using polymer initiators installed on proteins via site-specific enzymatic labeling. Here, the standard approach of linking polymers to proteins will be reversed by incorporating site-selectively positioned initiators that can be used to grow polymeric chains of various types; (3) Use enzymatic protein labeling to prepare protein conjugates based on fibronectin scaffolds for imaging and therapeutic applications. Fibronectin (Fn) scaffolds that target EGF receptors on cancer cells will be modified with either DOTA ligands for PET imaging applications or drugs for therapeutic experiments in mouse xenograft models; (4) Employ triorthogonal PFTase substrates to create chemically self-assembled nanoring structures (CSANs) that incorporate protein toxins for therapeutic applications. Nanostructures functionalized with diphtheria toxin or perforin will be used to target CD3+ T-cells for the treatment of Type 1 Diabetes and other autoimmune disorders. Successful completion of these highly significant and innovative Aims could have a major impact in the field of protein conjugates and on their use in promoting human health.

Public Health Relevance

This project seeks to develop methods that use enzymes to prepared modified proteins. If successful, the work described in this application could lead to improved protein-based drugs that could be employed for the treatment of autoimmune diseases and cancer. Of equal importance, the methods developed here could be used to create novel therapeutic agents for other diseases as well as reduce the cost of preparing existing drugs that are currently prohibitively expensive to produce.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM084152-05A1
Application #
9176887
Study Section
Macromolecular Structure and Function A Study Section (MSFA)
Program Officer
Edmonds, Charles G
Project Start
2010-05-01
Project End
2020-08-31
Budget Start
2016-09-01
Budget End
2017-08-31
Support Year
5
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Fisher, Stephanie A; Tam, Roger Y; Fokina, Ana et al. (2018) Photo-immobilized EGF chemical gradients differentially impact breast cancer cell invasion and drug response in defined 3D hydrogels. Biomaterials 178:751-766
Diaz-Rodriguez, Veronica; Hsu, Erh-Ting; Ganusova, Elena et al. (2018) a-Factor Analogues Containing Alkyne- and Azide-Functionalized Isoprenoids Are Efficiently Enzymatically Processed and Retain Wild-Type Bioactivity. Bioconjug Chem 29:316-323
Zhang, Yi; Park, Keun-Young; Suazo, Kiall F et al. (2018) Recent progress in enzymatic protein labelling techniques and their applications. Chem Soc Rev 47:9106-9136
Suazo, Kiall F; Hurben, Alexander K; Liu, Kevin et al. (2018) Metabolic Labeling of Prenylated Proteins Using Alkyne-Modified Isoprenoid Analogues. Curr Protoc Chem Biol 10:e46
Blanden, Melanie J; Suazo, Kiall F; Hildebrandt, Emily R et al. (2018) Efficient farnesylation of an extended C-terminal C(x)3X sequence motif expands the scope of the prenylated proteome. J Biol Chem 293:2770-2785
Wang, Yen-Chih; Distefano, Mark D (2016) Synthetic isoprenoid analogues for the study of prenylated proteins: Fluorescent imaging and proteomic applications. Bioorg Chem 64:59-65
Jennings, Benjamin C; Danowitz, Amy M; Wang, Yen-Chih et al. (2016) Analogs of farnesyl diphosphate alter CaaX substrate specificity and reactions rates of protein farnesyltransferase. Bioorg Med Chem Lett 26:1333-6
Mahmoodi, M Mohsen; Abate-Pella, Daniel; Pundsack, Tom J et al. (2016) Nitrodibenzofuran: A One- and Two-Photon Sensitive Protecting Group That Is Superior to Brominated Hydroxycoumarin for Thiol Caging in Peptides. J Am Chem Soc 138:5848-59
Mahmoodi, M Mohsen; Fisher, Stephanie A; Tam, Roger Y et al. (2016) 6-Bromo-7-hydroxy-3-methylcoumarin (mBhc) is an efficient multi-photon labile protecting group for thiol caging and three-dimensional chemical patterning. Org Biomol Chem 14:8289-300
Wickramaratne, Susith; Ji, Shaofei; Mukherjee, Shivam et al. (2016) Bypass of DNA-Protein Cross-links Conjugated to the 7-Deazaguanine Position of DNA by Translesion Synthesis Polymerases. J Biol Chem 291:23589-23603

Showing the most recent 10 out of 38 publications